Angola vs Mexico: The number of people with susceptibility test result for rifampicin
Angola
33.12
in 2021
Mexico
35.3
in 2021
Angola rank
130th
Mexico rank
128th
The number of people with susceptibility test result for rifampicin over time
- Angola
- Mexico
How they compare
Mexico currently reports 35.3 against 33.12 in Angola, a difference of 2.18.
That makes Mexico's figure about 1.1 times Angola's.
The two have swapped places 3 times across 5 shared years of data; in 2017 it was Angola ahead.
Angola ranks 130th and Mexico ranks 128th of 146 countries.
Across the 2 decades both report, Angola averaged higher in 1 and Mexico in 1.
Head to head by decade
| Decade | Angola | Mexico | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 28.65 | 1.27 | 27.38 | Angola |
| 2020s | 18.32 | 29.51 | 11.18 | Mexico |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Angola or Mexico?
- Mexico, at 35.3 against 33.12 in Angola as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Angola and Mexico?
- 2.18, with Mexico ahead.
- How many years of comparable data are there for Angola and Mexico?
- 5 years are reported by both, from 2017 to 2021.
- How do Angola and Mexico rank globally for the number of people with susceptibility test result for rifampicin?
- Angola ranks 130th and Mexico ranks 128th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.